These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 13952193)

  • 1. Agranulocytosis with alpha methyl DOPA.
    HALLWRIGHT GP
    N Z Med J; 1962 Sep; 61():470-2. PubMed ID: 13952193
    [No Abstract]   [Full Text] [Related]  

  • 2. Agranulocytosis caused by methyl dopa (Aldomet).
    HALLWRIGHT GP
    N Z Med J; 1961 Dec; 60():567-70. PubMed ID: 13903962
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of alpha methyl dopa and alpha methyl dopa hydrazine with L-dopa therapy.
    Mones RJ
    N Y State J Med; 1974 Jan; 74(1):47-51. PubMed ID: 4591989
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of alpha methyl-dopa.
    SPERBER RJ; DEGRAFF AC
    Am Heart J; 1963 Feb; 65():275-6. PubMed ID: 13990064
    [No Abstract]   [Full Text] [Related]  

  • 5. [Etiology and treatment of retinitis pigmentosa. XI. Clinical results with alpha-methyl-DOPA].
    OYA T; KUNO Y
    Rinsho Ganka; 1963 Mar; 17():248-54. PubMed ID: 13940864
    [No Abstract]   [Full Text] [Related]  

  • 6. DISSOCIATION OF THE DECARBOXYLASE-INHIBITING AND NOREPINEPHRINE-DEPLETING EFFECTS OF ALPHA-METHYL-DOPA, ALPHA-ETHYL-DOPA, 4-BROMO-3-HYDROXY-BENZYLOXYAMINE AND RELATED SUBSTANCES.
    LEVINE RJ; SJOERDSMA A
    J Pharmacol Exp Ther; 1964 Oct; 146():42-7. PubMed ID: 14221224
    [No Abstract]   [Full Text] [Related]  

  • 7. [CLINICAL EXPERIENCES WITH ALPHA-METHYL-DOPA, A DECARBOXYLASE INHIBITOR].
    RIPKA O
    Cas Lek Cesk; 1965 Feb; 104():173-5. PubMed ID: 14308252
    [No Abstract]   [Full Text] [Related]  

  • 8. Intraocular pressure studies with alpha-methyl-dopa.
    LAIBSON PR; KRISHNAN ; LEOPOLD IH
    Arch Ophthalmol; 1962 Nov; 68():648-50. PubMed ID: 13928121
    [No Abstract]   [Full Text] [Related]  

  • 9. Spontaneous formation of conjugates of alpha-methyl-DOPA and DOPA with serum proteins and experimental production of specific antibodies against these haptens.
    Cîrstea M; Suhaciu G; Cîrje M
    Physiologie; 1983; 20(1):3-10. PubMed ID: 6405406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spurious elevation of urinary catecholamines during therapy with alpha-methyl-dopa. A diagnostic pitfall.
    GIFFORD RW; TWEED DC
    JAMA; 1962 Oct; 182():493-5. PubMed ID: 13947776
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies of the modification of central effects of 3,4-dioxyphenyl-alanine (DOPA) by alpha-methyl-dioxyphenylalanine (alpha-methyl-DOPA)].
    Matthies H; Fähse C; Lietz W
    Acta Biol Med Ger; 1967; 19(4):529-34. PubMed ID: 5596674
    [No Abstract]   [Full Text] [Related]  

  • 12. In-vivo decarboxylation of alpha-methyl DOPA and alpha-methyl metatyrosine.
    CARLSSON A; LINDQVIST M
    Acta Physiol Scand; 1962 Jan; 54():87-94. PubMed ID: 13876658
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effects of reserpine, guanethidine and alpha-methyl-DOPA on resistance to cold].
    POULIOT M; LEBLANC J
    Arch Int Physiol Biochim; 1963 Jan; 71():73-82. PubMed ID: 13985777
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of alpha-methyl DOPA on the metabolism of 5-hydroxythryptamine in brain.
    ROOS BE; WERDINIUS B
    Life Sci (1962); 1963 Feb; 2():92-6. PubMed ID: 13974700
    [No Abstract]   [Full Text] [Related]  

  • 15. Alpha-methyldopa: antihypertensive drug with unusual mechanism of action.
    SJOERDSMA A
    Heart Bull; 1963; 12():1-4. PubMed ID: 13977819
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of carcinoid syndrome, with an account of the use of alpha-methyl-dopa.
    NOBLE NR
    Med J Aust; 1961 Oct; 48(2)():589-92. PubMed ID: 14480157
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the therapeutic use of alpha-methyl-DOPA in the carcinoid syndrome].
    DUBACH UC; BLUMBERG A
    Klin Wochenschr; 1961 Sep; 39():973. PubMed ID: 13888006
    [No Abstract]   [Full Text] [Related]  

  • 18. [Stability and dissociation constants of L-dopa and alpha-L-methyldopa].
    Lippold BC; Jaeger I
    Arch Pharm (Weinheim); 1973 Feb; 306(2):106-17. PubMed ID: 4694922
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of L-alpha-methyl DOPA and N-2-hydroxybenzyl-N-methyl hydrazine (NSD 1039) on the blood pressure of renal hypertensive rates.
    DAVIS RA; DRAIN DJ; HORLINGTON M; LAZARE R; URBANSKA A
    Life Sci (1962); 1963 Mar; 3():193-7. PubMed ID: 14025509
    [No Abstract]   [Full Text] [Related]  

  • 20. [ACTION OF ALPHA-METHYLDOPA (AMD) ON EMOTIONAL BEHAVIOR OBJECTIFIED BY "GROUP TOXICITY" PRODUCED BY DL-AMPHETAMINE AND DL-DIHYDROXYPHENYLALANINE IN MICE].
    HALPERN BN; DRUDI-BARACCO C; BESSIRARD D
    C R Seances Soc Biol Fil; 1963 Dec; 157():1421-6. PubMed ID: 14091868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.